Target Name: RSPH9
NCBI ID: G221421
Review Report on RSPH9 Target / Biomarker Content of Review Report on RSPH9 Target / Biomarker
RSPH9
Other Name(s): Radial spoke head protein 9 homolog (isoform 2) | Radial spoke head 9 homolog (Chlamydomonas, RSPH9) | Radial spoke head component 9, transcript variant 1 | MRPS18AL1 | RSPH9_HUMAN | FLJ30845 | radial spoke head 9 homolog | Radial spoke head protein 9 homolog | RSPH9 variant 2 | radial spoke head component 9 | RSPH9 variant 1 | C6orf206 | CILD12 | Radial spoke head component 9, transcript variant 2 | Radial spoke head protein 9 homolog (isoform 1)

Understanding The Radial Spoke-Like Structure of RSPH9

Radial spoke head protein 9 (RSPH9) is a protein that is found in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the spoke head protein family, which includes a variety of proteins that are involved in various cellular processes, including signaling and cytoskeletal organization.

One of the unique features of RSPH9 is its ability to form a radial spoke-like structure in various cellular organelles. This structure is composed of a series of interconnected actin filaments that are arranged in a radial pattern. This structure is thought to play a role in the regulation of cellular processes such as cell division, migration, and cytoskeletal organization.

RSPH9 has also been shown to be involved in a variety of signaling pathways. For example, it has been shown to play a role in the regulation of cell proliferation and differentiation, as well as in the regulation of ion channels and neurotransmitter release. Additionally, RSPH9 has been shown to interact with a variety of intracellular signaling molecules, including tyrosines, mitogen-activated kinases, and neurotransmitter receptors.

Due to its involvement in these various cellular processes, RSPH9 is thought to be a potential drug target or biomarker. For example, various studies have suggested that inhibiting RSPH9 activity may have therapeutic benefits for a variety of diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Additionally, RSPH9 has been shown to be involved in a variety of cellular processes that are implicated in aging and age-related diseases, which may make it an attractive target for therapies aimed at preventing or treating these conditions.

In conclusion, RSPH9 is a protein that is involved in a variety of cellular processes throughout the body, including signaling and cytoskeletal organization. Its unique radial spoke-like structure and its involvement in various signaling pathways make it a potential drug target or biomarker. Further research is needed to fully understand the role of RSPH9 in cellular processes and its potential as a therapeutic target or biomarker.

Protein Name: Radial Spoke Head Component 9

Functions: Functions as part of axonemal radial spoke complexes that play an important part in the motility of sperm and cilia (PubMed:19200523). Essential for both the radial spoke head assembly and the central pair microtubule stability in ependymal motile cilia (By similarity). Required for motility of olfactory and neural cilia and for the structural integrity of ciliary axonemes in both 9+0 and 9+2 motile cilia (By similarity)

The "RSPH9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RSPH9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RSPO1 | RSPO2 | RSPO3 | RSPO4 | RSPRY1 | RSRC1 | RSRC2 | RSRP1 | RSU1 | RSU1P2 | RTBDN | RTCA | RTCB | RTEL1 | RTEL1-TNFRSF6B | RTF1 | RTF2 | RTKN | RTKN2 | RTL1 | RTL10 | RTL3 | RTL4 | RTL5 | RTL6 | RTL8A | RTL8B | RTL8C | RTL9 | RTN1 | RTN2 | RTN3 | RTN4 | RTN4IP1 | RTN4R | RTN4RL1 | RTN4RL2 | RTP1 | RTP2 | RTP3 | RTP4 | RTP5 | RTRAF | RTTN | RUBCN | RUBCNL | RUFY1 | RUFY2 | RUFY3 | RUFY4 | RUNDC1 | RUNDC3A | RUNDC3A-AS1 | RUNDC3B | RUNX1 | RUNX1-IT1 | RUNX1T1 | RUNX2 | RUNX2-AS1 | RUNX3 | RUNX3-AS1 | RUSC1 | RUSC1-AS1 | RUSC2 | RUSF1 | RUVBL1 | RUVBL1-AS1 | RUVBL2 | RWDD1 | RWDD2A | RWDD2B | RWDD3 | RWDD3-DT | RWDD4 | RXFP1 | RXFP2 | RXFP3 | RXFP4 | RXRA | RXRB | RXRG | RXYLT1 | Ryanodine receptor | RYBP | RYK | RYR1 | RYR2 | RYR3 | RZZ complex | S100 Calcium Binding Protein | S100A1 | S100A10 | S100A11 | S100A11P1 | S100A12 | S100A13 | S100A14 | S100A16 | S100A2 | S100A3